Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Lucentis was the first VEGF inhibitor to reach the market for wet AMD and grew quickly into a blockbuster product with sales of around $3.7bn last year. ... Alteogen and Momenta/Mylan have versions of Eylea in development, while Coherus and Xbrane Pharma

Novartis bags US okay for Lucentis follow-up Beovu in wet AMD

Novartis bags US okay for Lucentis follow-up Beovu in wet AMD The green light for Beovu (brolucizumab) is a boost for Novartis as it tries to defend its  wet AMD franchise, currently represented by $2bn-plus VEGF inhibitor product  Lucentis (ranibizumab) which ... That compares to four to eight week dosing with

Alcon spun off, leaner Novartis raises profit forecast

Alcon spun off, leaner Novartis raises profit forecast These include rare disease gene therapy Zolgensma, breast cancer candidate alpelisib (BYL719)  and Lucentis follow-up brolucizumab.

Bayer to challenge Avastin legal ruling

Bayer to challenge Avastin legal ruling age-related macular degeneration (wet AMD) in place of two licensed but much more expensive treatments, Bayer’s Eylea and Novartis’ Lucentis. ... carried out to establish its equivalence in safety and efficacy with Lucentis in particular.

After Lucentis setback, Novartis trumpets data on follow-up drug

After Lucentis setback, Novartis trumpets data on follow-up drug of Lucentis and Eylea for AMD, even though Avastin isn’t approved for the indication. ... The US patents on Lucentis and Eylea will both expire in 2020, and in 2022 for Lucentis and 2021 for Eylea in Europe.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics